Global Biomanufacturing Viral Detection and Quantification Market Size is valued at USD 466.52 Million in 2022 and is predicted to reach USD 981.41 Million by the year 2031 at a 8.8% CAGR during the forecast period for 2023 to 2031.
Biomanufacturing Viral Detection and Quantification Market Size, Share & Trends Analysis Report By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, and Others), Application, End User, Region, And Segment Forecasts, 2026 to 2035
Viral clearance is necessary during the downstream purification of therapeutic biologics, blood, and tissue-derived materials. Viruses are either removed or inactivated for manufacturing microbiologically stable goods.
Reliable and fast viral detection and quantification techniques are required to advance basic research and clinical approaches. The biomanufacturing viral detection and quantification market is estimated to be driven by technological advancements in the viral testing domain and the increasing demand for biopharmaceutical products.
Due to the increasing utilization of biopharmaceuticals, the biomanufacturing viral detection and quantification market is growing rapidly. Quality control systems are essential to ensure biopharmaceuticals' safety, efficacy and consistency. This increases the demand for consumables and equipment for the identification & quantification of viral contaminants in the biomanufacturing process of biological products, thereby promoting the growth of the biomanufacturing viral detection and quantification market.
The Biomanufacturing Viral Detection and Quantification Market is segmented based on offering type, technology, application, and end user. The offering type segment includes consumables, instruments, and services. By technology, the market is bifurcated into PCR, ELISA, flow cytometry, plaque assay, and others. By application, the market is categorized into blood and blood products manufacturing, vaccines and therapeutics manufacturing, cellular and gene therapy products manufacturing, stem cell products manufacturing, and tissue and tissue products manufacturing. Based on end user, the market is divided into life science companies, testing laboratories, CROs and CDMOs.
Based on offering type, the consumables segment dominated the biomanufacturing viral detection and quantification market in 2022. The surging adoption of kits, assays, monitoring and additional equipment has led to a significant increase in the consumables segment. Consumables are products and materials that are continuously used throughout the viral detection and quantification process. Many consumables are used in viral testing to determine the quantity or concentration of a particular virus in biological samples.
By Technology, PCR Technology Segment is expected to grow at the highest rate in the biomanufacturing viral detection and quantification market during the forecast period.
Virus detection and testing using polymerase chain reaction (PCR) technology has the advantage of high sensitivity and reproducibility. PCR testing can identify the development of the infection, monitor the response to treatment, and distinguish latent from active infection. Also, in virus monitoring, PCR assays help identify false positive results caused by inadvertent contamination of samples with traces of viral nucleic acids or PCR products.
Based on application, the biomanufacturing viral detection and quantification market was led by the blood and blood products manufacturing segment in 2022. Viral testing identifies and measures viral nucleic acids in blood samples and helps maintain the safety and quality of blood & blood products.
In terms of end users, the life science companies segment dominated the biomanufacturing viral detection and quantification market in 2022.
Maintaining quality control measures in the life sciences industries is crucial to manufacturing products with high safety, quality and efficiency. Viral detection and quantification methods are used at the drug/therapy development, production, and testing stages.
North America held the largest share of the biomanufacturing viral detection and quantification market in 2022 and is predicted to continue its trend over the forecast period, owing to the presence of most key players, increased demand for cell & gene therapies, advancements in viral detection and quantification technologies. Furthermore, the Asia Pacific market is expected to accelerate over the projected period (2023-2031), owing to the continuous R&D efforts in the viral detection and quantification industry, the high utilization of biopharmaceutical products, and the rising funding for innovative therapy research.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 466.52 Million |
| Revenue Forecast In 2031 | USD 981.41 Million |
| Growth Rate CAGR | CAGR of 8.8 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Offering Type, Technology, Application, End User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Danaher Corporation, Merck KGaA, New England Biolabs, TAKARA HOLDINGS INC., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Genscript Biotech Corporation, Norgen Biotek Corp., and others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.